medigraphic.com
ISSN 2954-3835 (Digital)
ISSN 2683-2828 (Impreso)

2023, Número 3

<< Anterior Siguiente >>

Cardiovasc Metab Sci 2023; 34 (3)


Una reflexión sobre los resultados de la ENSANUT 2022 sobre hipertensión arterial en adultos mexicanos

Alcocer L, Rosas-Peralta M, Guerra-López A, Alcocer A, Palomo S, Cossio JE, Enciso JM, Salgado-Loza JL, Meaney E

Idioma: Inglés [English version]
Referencias bibliográficas: 44
Paginas: 85-93
Archivo PDF: 240.86 Kb.





REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kilpelainen K, Koponen P, Tolonen H, Koskinen S, Borodulin K, Gissler M. From monitoring to action: utilizing health survey data in national policy development and implementation in Finland. Arch Public Health. 2019; 77: 48. doi: 10.1186/s13690-019-0374-9.

  2. Ortiz-Pérez H, Bravo-García E. Las encuestas nacionales de salud 1986-2021: instrumento fundamental de la Salud Pública en México. Disponible en: https://dsp.facmed.unam.mx/wp-content/uploads/2022/10/COVID-19-No.29-03-Las-Encuestas-Nacionales-de-Salud-1986-2021.pdf

  3. Campos-Nonato I, Oviedo-Solís C, Vargas-Meza J, Ramírez-Villalobos D, Medina-García C, Gómez-Álvarez E et al. Prevalence, treatment, and control of hypertension in Mexican adults: results of the Ensanut 2022. Salud Publica Mex. 2023; 65 (Supl 1): S169-S180. doi: 10.21149/14779.

  4. Arroyo P, Fernández V, Loria A, Kuri-Morales P, Orozco-Rivadeneyra S, Olaiz G et al. Hypertension in urban Mexico: the 1992-93 national survey of chronic diseases. J Hum Hypertens. 1999; 13: 671-675. doi: 10.1038/sj.jhh.1000909.

  5. Velázquez Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelín Hernández G, Grupo ENSA 2000, Attie F et al. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Méx. 2002; 72: 71-84.

  6. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villalpando-Hernández S, Hernández-Avila M et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2006.

  7. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX); 2012.

  8. Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Medina C, Barquera S. Hipertensión arterial en adultos mexicanos: prevalencia, diagnóstico y tipo de tratamiento. Ensanut MC 2016. Salud Publica Mex. 2018; 60: 233-243. doi: 10.21149/8813.

  9. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud 2018. Disponible en: https://ensanut.insp.mx/encuestas/ensanut2018/doctos/informes/ensanut_2018_presentacion_resultados.pdf

  10. Campos-Nonato I, Hernández-Barrera L, Flores-Coria A, Gómez-Álvarez E, Barquera S. Prevalencia, diagnóstico y control de hipertensión arterial en adultos mexicanos en condición de vulnerabilidad. Resultados de la Ensanut 100k, Salud Publica Mex. 2019; 61: 888-897. doi: 10.21149/10574.

  11. Campos-Nonato I, Hernández-Barrera L, Oviedo-Solís C, Ramírez-Villalobos D, Hernández-Prado B, Barquera S. Epidemiología de la hipertensión arterial en adultos mexicanos: diagnóstico, control y tendencias. Ensanut 2020. Salud Publica Mex. 2021; 63: 692-704. doi: 10.21149/12851.

  12. Shamah-Levy T, Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA et al. Encuesta Nacional de Salud y Nutrición 2021 sobre Covid-19. Resultados nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública; 2022.

  13. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018; 71: e127-e248. doi: 10.1016/j.jacc.2017.11.00622.

  14. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507-520. doi: 10.1001/jama.2013.284427.

  15. Weber MA. Recently published hypertension guidelines of the JNC 8 panelists, the American Society of Hypertension/International Society of Hypertension and other major organizations: Introduction to a focus issue of The Journal of Clinical Hypertension. J Clin Hypertens (Greenwich). 2014; 16: 241-245. doi: 10.1111/jch.12308.

  16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. National heart, lung, and blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560-2572. doi: 10.1001/jama.289.19.2560.

  17. Barquera S, Campos-Nonato I, Hernández-Barrera L, Villalpando S, Rodríguez-Gilabert C, Durazo-Arvizú R et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex. 2010; 52 suppl 1: S63-S67.

  18. Muniyandi M, Sellappan S, Chellaswamy V, Ravi K, Karthikeyan S, Thiruvengadam K. Diagnostic accuracy of mercurial versus digital blood pressure measurement devices: a systematic review and meta-analysis. Sci Rep. 2022; 12: 3363. doi: 10.1038/s41598-022-07315-z.

  19. Modificación a la Norma Oficial Mexicana NOM-030-SSA2-1999, Para la prevención, tratamiento y control de la hipertensión arterial, para quedar como Norma Oficial Mexicana NOM-030-SSA2-2009, Para la prevención, detección, diagnóstico, tratamiento y control de la hipertensión arterial sistémica. Diario Oficial de la Federación 31/05/2010 [visited on July the 2nd, 2023]. Disponible en: https://dof.gob.mx/nota_detalle_popup.php?codigo=5144642

  20. PROYECTO de Norma Oficial Mexicana PROY-NOM-030-SSA2-2017, Para la prevención, detección, diagnóstico, tratamiento y control de la hipertensión arterial sistémica. Diario Oficial de la Federación 19/04/2017 [visited on July the 2nd, 20230]. Disponible en: https://dof.gob.mx/nota_detalle.php?codigo=5480159&fecha=19/04/2017#gsc.tab=0

  21. Meaney A, Ceballos-Reyes G, Gutiérrez-Salmeán G, Samaniego-Méndez V, Vela-Huerta A, Alcocer A et al. Cardiovascular risk factors in a Mexican middle-class urban population. The Lindavista Study. Baseline data. Arch Cardiol Méx. 2013; 83: 249-256. doi: 10.1016/j.acmx.2013.05.002.

  22. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. ESC Scientific Document Group. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39: 3021-3104. doi: 10.1093/eurheartj/ehy339

  23. Whelton PK, Carey RM, Mancia G, Kreutz R, Bundy JD, Williams B. Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations. Circulation. 2022; 146: 868-877. doi: 10.1161/CIRCULATIONAHA.121.054602.

  24. Unger T, Borghi C, Chrchar F, Khan NA, Poulter NR, Prabhakaran D et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75: 1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026.

  25. Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM et al. Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020; 36: 596-624. doi: 10.1016/j.cjca.2020.02.086.

  26. Kario K. Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension. Korean Circ J. 2019; 49: 1123-1135. doi: 10.4070/kcj.2019.0246.

  27. Kim HC, Ihm SH, Kim GH et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part I-epidemiology of hypertension. Clin Hypertens. 2019; 25: 16. doi: 10.1186/s40885-019-0121-0.

  28. Liu J. Highlights of the 2018 Chinese hypertension guidelines. Clin Hypertens. 2020; 26: 8. doi: 10.1186/s40885-020-00141-3.

  29. Haarrap SB, Lung T, Chalmers J. New blood pressure guidelines pose difficult choices for Australian physicians. Circulation Research. 2019; 124: 975-977. doi: 10.1161/CIRCRESAHA.118.314637.

  30. NICE guideline Published: 28 August 2019. Last updated: 18 March 2022. Hypertension in adults: diagnosis and management. [Visited on July the 2nd, 2023] Available in: www.nice.org.uk/guidance/ng136

  31. Malachias MVB, Gomes MAM, Nobre F, Alessi A, Feitosa AD, Coelho EB. 7th Brazilian Guideline of Arterial Hypertension: Chapter 2 - Diagnosis and Classification. Arq Bras Cardiol. 2016; 107 (3 Suppl 3): 7-13. doi: 10.5935/abc.20160152.

  32. Task Force of the Latin American Society of Hypertension. Guidelines. J Hypertens. 2017; 35: 1529-1545. doi: 10.1097/HJH.0000000000001418.

  33. Consenso Argentino de Hipertensión Arterial. RAC. 2018; 86 (supl 2): 5-53.

  34. American Academy of Family Physicians. AAFP Issues New Clinical Practice Guideline on Hypertension. Ann Fam Med. 2023; 21: 190-191. doi: 10.1370/afm.2972.

  35. Qaseem A, Wilt TJ, Rich R, Humphrey LL, Fros J, Forciea MA. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017; 166: 430-437. doi: 10.7326/M16-1785.

  36. Hidalgo I, González B, Nájera N, Ceballos G, Meaney E. A minireview of high blood pressure prevalence in some contemporary hunter or fisher-gatherer communities. Cardiovasc Metab Sci. 2022; 33: 187-195. doi: 10.35366/109246.

  37. Varki A, Altheide TK. Comparing the human and chimpanzee genomes: searching for needles in a haystack. Genome Res. 2005; 15: 1746-1758. doi: 10.1101/gr.3737405.

  38. Jensen B, Wang T. Apes, adaptations, and artifacts of anesthetics. Proc Natl Acad Sci U S A. 2020; 117 (11): 5573. doi: 10.1073/pnas.1921494117.

  39. Ely JJ, Zavaskis T Lammey ML, Rick Lee D. Blood pressure reference intervals for healthy adult chimpanzees (Pan troglodytes). J Med Primatol. 2011; 40: 171-180. doi: 10.1111/j.1600-0684.2011.00467.x.

  40. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-1913. doi: 10.1016/s0140-6736(02)11911-8.

  41. Mancia G, Grassi G. Aggressive blood pressure lowering is dangerous: The J-Curve pro side of the argument. Hypertension. 2014; 63: 29-36. doi: 10.1161/HYPERTENSIONAHA.113.01922.

  42. SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373: 2103-2116. doi: 10.1056/NEJMoa1511939.

  43. Ranganathan P, Pramesh CS, Aggarwal R. Common pitfalls in statistical analysis: Absolute risk reduction, relative risk reduction, and number needed to treat. Perspect Clin Res. 2016; 7: 51-53. doi: 10.4103/2229-3485.173773.

  44. Drawz PE, Ix JH. BP measurement in clinical practice: time to SPRINT to guideline-recommended protocols. J Am Soc Nephrol. 2018; 29: 383-388. doi: 10.1681/ASN.2017070753.




2020     |     www.medigraphic.com